Search

everythinglearnresearchcommunity

for

Search:↓

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Male pattern baldness is mostly inherited, involves many genes, and is linked to other traits like early puberty and strong bones.

Testosterone may slow down wound healing and increase inflammation.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

The conclusion is that understanding how feathers and hairs pattern can help in developing hair regeneration treatments.

Male hormones affect oil-producing skin cells differently based on their body location, and the drug spironolactone can reduce these effects.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Different processes create patterns in skin and things like hair and feathers.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Red deer only have androgen receptors in neck hair cells for mane growth during breeding season.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

SVF-PRP therapy effectively reverses hair loss effects.

Men with male pattern baldness have a higher risk of certain skin cancers, especially on the scalp.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Thyroid hormones and androgens affect gene expression in frog reproductive organs differently between males and females.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

A substance called Vascular Endothelial Growth Factor can protect certain hair follicle stem cells from damage caused by androgens, suggesting a new possible treatment for hair loss.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

The length of CAG repeats in the androgen receptor gene is linked to ovarian reserve but does not affect how the ovaries respond to stimulation.

QR 678 and QR678 Neo treatments are effective for hair loss in women with PCOS.

Certain gene variations increase male hair loss risk, influenced by hormone levels.

AR gene variations don't affect aging markers in men.

Certain Prakruti types are more prone to early male pattern baldness.

A multidisciplinary approach is crucial for managing Silver-Russell syndrome effectively.

VEGFR-2 activation is likely involved in hair follicle growth, survival, and development.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.